A detailed history of New England Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, New England Asset Management Inc holds 15,135 shares of ABT stock, worth $1.74 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
15,135
Previous 16,200 6.57%
Holding current value
$1.74 Million
Previous $1.68 Million 2.5%
% of portfolio
0.29%
Previous 0.3%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$100.07 - $118.13 $106,574 - $125,808
-1,065 Reduced 6.57%
15,135 $1.73 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $733,784 - $810,432
-6,700 Reduced 29.26%
16,200 $1.84 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $380,591 - $456,646
-3,984 Reduced 14.82%
22,900 $2.22 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $45,628 - $53,529
-480 Reduced 1.75%
26,884 $2.95 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $48,993 - $59,217
480 Added 1.79%
27,364 $2.97 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $125,422 - $152,944
1,100 Added 4.27%
26,884 $3.18 Million
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $9,164 - $11,129
100 Added 0.39%
25,784 $2.81 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $37,692 - $55,116
600 Added 2.39%
25,684 $2.03 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $72,842 - $88,066
1,100 Added 4.59%
25,084 $2.01 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $27,535 - $31,193
-420 Reduced 1.72%
23,984 $1.74 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $402,990 - $444,780
-7,000 Reduced 22.29%
24,404 $1.49 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $84,405 - $95,430
-1,500 Reduced 4.56%
31,404 $1.88 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $144,936 - $155,169
-2,700 Reduced 7.58%
32,904 $1.88 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $1.71 Million - $1.91 Million
35,604
35,604 $1.9 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track New England Asset Management Inc Portfolio

Follow New England Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on New England Asset Management Inc with notifications on news.